Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zanaflex

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Zanaflex is an essential compound useful in treating serious illnesses. It will be used to produce capsules or tablets for the treatment of spinal cord injuries or multiple sclerosis as well as brain injuries and strokes.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals

Zanaflex Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Zanaflex‘s full profile, request access.

Request full access to PitchBook